Back to Search Start Over

BASELINE ANTI-NS4A ANTIBODIES IN COMBINATION WITH ON-TREATMENT QUANTITATIVE HCV-RNA RELIABLY IDENTIFIES NON RESPONDERS TO PEGINTERFERON-RIBAVIRIN COMBINATION THERAPY AFTER 4 WEEKS OF TREATMENT

Authors :
Orlent, Hans
Desombere, Isabelle
Hansen, Bettina E.
Vlierberghe, Hans
Haagmans, Bart
Robert De Knegt
Schalm, Solko W.
Leroux-Roels, Geert
Janssen, Harry L.
Source :
Web of Science, Publons

Details

Database :
OpenAIRE
Journal :
Web of Science, Publons
Accession number :
edsair.dedup.wf.001..7726eacbf56994a2f3e21ca6fd3400bc

Tools

Authors Abstract Subjects Details